Philippines' Duterte warns he'll jail people who refuse the COVID-19 vaccine
Do not pass go, do not collect $200 — if you're in the Philippines and refuse the COVID-19 vaccine, President Rodrigo Duterte wants you to go directly to jail.
"You choose, vaccine or I will have you jailed," Duterte said on Monday during a televised address. The Philippines has reported more than 1.3 million COVID-19 cases and over 23,000 deaths. There is low turnout at vaccination sites in Manila, and while health officials have stressed the importance of the vaccine, they also have made it clear it's voluntary, Reuters reports.
Duterte has decided to try to a different approach. There is "a crisis in this country," he said. "I'm just exasperated by Filipinos not heeding the government." As of Sunday, 2.1 million Filipinos have been fully vaccinated. There are 110 million people living in the Philippines, and the government has said its goal is to inoculate 70 million by the end of the year.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Duterte is known for his hardline stance on most things — he has waged a war on drugs since being elected in 2016, and thousands have been killed in the campaign. A prosecutor with the International Criminal Court has asked to investigate these deaths, but Duterte on Monday said he will not cooperate. "Why would I defend or face an accusation before white people," he said. "You must be crazy."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
The best new music of 2024 by genre
The Week Recommends Outstanding albums, from pop to electro and classical
By The Week UK Published
-
Nine best TV shows of 2024 to binge this Christmas
The Week Recommends From Baby Reindeer and Slow Horses to Rivals and Shogun, here are the critics' favourites
By The Week UK Published
-
Crossword: December 28, 2024
The Week's daily crossword puzzle
By The Week Staff Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published